Regular, moderate red wine consumption has been linked to decreased risk of various cancers and heart disease. The antioxidant flavonoids in wine are from its red grape origins. Specifically, phytoalexin resveratrol from red grapes has been shown in cell studies to not only bolster immune defense, but also reduce tumor incidence and stall growth of many cancer cells.

This flavonoid has anti-inflammatory properties that have been studied as chemopreventive against three stages of the cancer process—initiation, promotion and progression. Proanthocyanins have exhibited similar abilities to stifle carcinoma cells and counteract chemotherapy effects on normal cells.

Resveratrol
Certain proprietary grape extracts containing various degrees of resveratrol, anthocyanins and proanthocyanins have demonstrated in research to impact CHD by reducing cell adhesion to the endothelium, influencing lipid peroxidation, reducing LDL oxidation, preventing aortic atherosclerosis and lowering systolic blood pressure in hypertensive rats.

Further research on grape flavonoids has shown benefits to people suffering HIV, dementia and diabetes.

Posted: 01|23|07 at 6:35 pm. Filed under: News.